In this review:
Vaccination of infants in mothers exposed to anti-TNF agents
Baseline RF and ACPA screening sufficient for seronegative RA
Complementary medicine use common in inflammatory arthritis
Screening prior to the use of biologic agents
Higher BMI in PsA reduces treatment success
Long-term safety & efficacy of tofacitinib in PsA
The disease burden of non-radiographic SpA
Negative beliefs about back pain perpetuate back pain
Ixekizumab shows promise in PsA
Patients accept biosimilars recommended by rheumatologists
Please login below to download this issue (PDF)